Picture of Immuno-Biological Laboratories logo

4570 — Immuno-Biological Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Table: Immuno Biological Lab -Q1 group results

Aug 8 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            229 mln             177 mln          925 mln   
                 (+29.6 pct)         (+13.3 pct)      (+13.3 pct) 
  Operating        51 mln               0 mln           120 mln   
                                                      (+15.1 pct) 
  Recurring        56 mln              13 mln           120 mln   
                (+318.5 pct)                          (-4.3 pct)  
  Net              51 mln              11 mln           115 mln   
                (+359.9 pct)                          (-38.4 pct) 
  EPS             5.51 yen            1.19 yen         12.30 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T

Recent news on Immuno-Biological Laboratories

See all news